Persistent oxygen-glucose deprivation induces astrocytic death through two different pathways and calpain-mediated proteolysis of cytoskeletal proteins during astrocytic oncosis.
Astrocytes are thought to play a role in the maintenance of homeostasis and the provision of metabolic substrates for neurons as well as the coupling of cerebral blood flow to neuronal activity. Accordingly, astrocytic death due to various types of injury can critically influence neuronal survival. The exact pathway of cell death after brain ischemia is under debate. In the present study, we used astrocytes from rat primary culture treated with persistent oxygen-glucose-deprivation (OGD) as a model of ischemia to examine the pathway of cell death and the relevant mechanisms. We observed changes in the cellular morphology, the energy metabolism of astrocytes, and the percentage of apoptosis or oncosis of the astrocytes induced by OGD. Electron microscopy revealed the co-existence of ultrastructural features in both apoptosis and oncosis in individual cells. The cellular ATP content was gradually decreased and the percentages of apoptotic and oncotic cells were increased during OGD. After 4h of OGD, ATP depletion to less than 35% of the control was observed, and oncosis became the primary pathway for astrocytic death. Increased plasma membrane permeability due to oncosis was associated with increased calpain-mediated degradation of several cytoskeletal proteins, including paxillin, vinculin, vimentin and GFAP. Pre-treatment with the calpain inhibitor 3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid (PD150606) could delay the OGD-induced astrocytic oncosis. These results suggest that there is a narrow range of ATP that determines astrocytic oncotic death induced by persistent OGD and that calpain-mediated hydrolysis of the cytoskeletal-associated proteins may contribute to astrocytes oncosis.
Cao
Xu
X
Department of Neurology, Second Clinical College, Jinan University, Shenzhen 518020, China.
Zhang
Ying
Y
Zou
Liangyu
L
Xiao
Haibing
H
Chu
Yinghao
Y
Chu
Xiaofan
X
D000179:Acrylates / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000166:cytology* / Q000378:metabolism / Q000648:ultrastructure; D002545:Brain Ischemia / Q000378:metabolism / Q000473:pathology; D002154:Calpain / Q000037:antagonists & inhibitors / Q000502:physiology*; D016923:Cell Death; D002463:Cell Membrane Permeability; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D017259:Dimaprit / Q000031:analogs & derivatives / Q000378:metabolism; D004734:Energy Metabolism; D005947:Glucose / Q000172:deficiency*; D006868:Hydrolysis; D010100:Oxygen / Q000378:metabolism*; D051381:Rats
D000179:Acrylates; D003598:Cytoskeletal Proteins; C100442:PD 150606; C071989:APT; D002154:Calpain; D005947:Glucose; D010100:Oxygen; D017259:Dimaprit